Technology Negative

24/7 Market News: Institutional Momentum Builds as Vanguard Group and Aramark Back VENU

Breaking news from global financial markets

2 months ago
Read More
24/7 Market News: Institutional Momentum Builds as Vanguard Group and Aramark Back VENU

24/7 Market News: Institutional Momentum Builds as Vanguard Group and Aramark Back VENU

Markets
2 months ago 4,778
Read More
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MLNK, IMXI on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MLNK, IMXI on Behalf of Shareholders

Legal
2 months ago 1,098
Read More
Lifeward appoints Almog Adar as CFO

Lifeward appoints Almog Adar as CFO

Ratings
2 months ago 1,434
Read More
Wellgistics Health launches XRP blockchain payment program for pharmacies

Wellgistics Health launches XRP blockchain payment program for pharmacies

Corporate
2 months ago 4,181
Read More
Gauzy reports Q2 results

Gauzy reports Q2 results

Ratings
2 months ago 3,826
Read More
Air Canada to suspend flights starting Thursday amid potential flight attendant strike

Air Canada to suspend flights starting Thursday amid potential flight attendant strike

Markets
2 months ago 3,133
Read More
SBC Medical Group Holdings Inc. (NASDAQ:SBC) Reports Q2 2025 Earnings Miss Amid Strategic Restructuring

SBC Medical Group Holdings Inc. (NASDAQ:SBC) Reports Q2 2025 Earnings Miss Amid Strategic Restructuring

Earnings
2 months ago 4,142
Read More
SIMULATIONS PLUS STOCK: Lose Money on Your Simulations Plus, Inc. (NASDAQ:SLP) Investment? Contact BFA Law about its Securities Investigation

SIMULATIONS PLUS STOCK: Lose Money on Your Simulations Plus, Inc. (NASDAQ:SLP) Investment? Contact BFA Law about its Securities Investigation

Legal
2 months ago 2,804
Read More
FLYWIRE STOCK: Lose Money on Your Flywire Corporation (NASDAQ:FLYW) Investment? Contact BFA Law before the September 23 Legal Deadline

FLYWIRE STOCK: Lose Money on Your Flywire Corporation (NASDAQ:FLYW) Investment? Contact BFA Law before the September 23 Legal Deadline

Legal
2 months ago 4,837
Read More
A Homebuyer Says, 'Potential House Is Trapped In A Solar Lease Scam,' Wonders If It's Now A Toxic, Uninvestable Property

A Homebuyer Says, 'Potential House Is Trapped In A Solar Lease Scam,' Wonders If It's Now A Toxic, Uninvestable Property

Markets
2 months ago 3,078
Read More
Madison Square Garden Entertainment Corp. (NYSE:MSGE) Reports Mixed Q4 Earnings, Stock Drops 4.8% in Pre-Market

Madison Square Garden Entertainment Corp. (NYSE:MSGE) Reports Mixed Q4 Earnings, Stock Drops 4.8% in Pre-Market

Ratings
2 months ago 1,775
Read More
Corn Clawing a Couple Cents Back on Wednesday Morning

Corn Clawing a Couple Cents Back on Wednesday Morning

Markets
2 months ago 1,569
Read More
Nvidia and Microsoft Stocks Have Reached a $4 Trillion Valuation. Is Apple Next?

Nvidia and Microsoft Stocks Have Reached a $4 Trillion Valuation. Is Apple Next?

Markets
2 months ago 2,375
Read More
PANTHERx® Rare Selected by Insmed to Dispense BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis

PANTHERx® Rare Selected by Insmed to Dispense BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis

Markets
2 months ago 2,327
Read More
Telitacicept Achieved Primary Endpoint in Phase 3 Clinical Study for Primary Sjögren's Disease with Telitacicept, a Dual BAFF/APRIL Inhibitor

Telitacicept Achieved Primary Endpoint in Phase 3 Clinical Study for Primary Sjögren's Disease with Telitacicept, a Dual BAFF/APRIL Inhibitor

Technology
2 months ago 2,379
Read More
Compass Lexecon Ranked Top Economic Consulting Firm on Lexology Index Competition 2025 List

Compass Lexecon Ranked Top Economic Consulting Firm on Lexology Index Competition 2025 List

Markets
2 months ago 1,455
Read More
Compass Lexecon Ranked Top Economic Consulting Firm on Lexology Index Competition 2025 List

Compass Lexecon Ranked Top Economic Consulting Firm on Lexology Index Competition 2025 List

Markets
2 months ago 4,759
Read More
Telitacicept Achieved Primary Endpoint in Phase 3 Clinical Study for Primary Sjögren's Disease with Telitacicept, a Dual BAFF/APRIL Inhibitor

Telitacicept Achieved Primary Endpoint in Phase 3 Clinical Study for Primary Sjögren's Disease with Telitacicept, a Dual BAFF/APRIL Inhibitor

Technology
2 months ago 4,305
Read More
PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System

PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System

Technology
2 months ago 1,599
Read More

Trending Now

1

ThinkCareBelieve: Week 42 of America's Climb into the Golden Age

38,460 38 minutes ago
2

Earnings To Watch: Jamf (JAMF) Reports Q3 Results Tomorrow

35,045 38 minutes ago
3

How Investors May Respond To Alarm.com Holdings (ALRM) Upbeat Q3 Results and Rai...

22,621 1 hour ago
4

A Look at Sabra Health Care REIT’s (SBRA) Valuation Following Senior Housing Gro...

31,847 1 hour ago
5

AeroVironment (AVAV): Evaluating Fair Value After Strong Three-Month Momentum

29,607 1 hour ago

Trending Topics

Sentiment (24h)

Positive
386
Neutral
107
Negative
84